Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
RESEARCH TOOLSreports
Syndax Pharmaceuticals (SNDX) Ownership - Who Owns Syndax Pharmaceuticals?
568 Followers
Syndax Pharmaceuticals (SNDX) Ownership Overview
1.06% Insiders
21.71% Mutual Funds
13.23% Other Institutional Investors
64.01% Public Companies and
Individual Investors
The ownership structure of Syndax Pharmaceuticals (SNDX) stock is a mix of institutional, retail and individual investors. Approximately 34.94% of the company’s stock is owned by Institutional Investors, 1.06% is owned by Insiders and 64.01% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 17, 2024 | Keith Goldan Cfo | xxxxxxxxxxxxx | $25025 |
| Aug 10, 2023 | Briggs Morrison Director | xxxxxxxxxxxxx | $965132 |
| Aug 03, 2023 | William Meury Director | xxxxxxxxxxxxx | $1697350 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $205536 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1908426 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $23158756 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $36754030 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,486,871 | Institution | 5.28% | 105,351,731 | |
| 4,249,352 | Institution | 5.00% | 99,774,785 | |
| 3,994,760 | Institution | 4.70% | 93,796,965 | |
| 3,692,337 | Institution | 4.34% | 86,696,073 | |
| 1,910,245 | Institution | 2.25% | 44,852,553 | |
| 1,544,287 | Institution | 1.82% | 36,259,859 | |
| 1,025,000 | Institution | 1.21% | 24,067,000 | |
| 973,057 | Institution | 1.14% | 22,847,378 | |
| 893,651 | Institution | 1.05% | 20,982,925 | |
| 833,961 | Institution | 0.98% | 19,581,404 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,249,352 | Institution | 5.00% | 99,774,785 | |
| 3,994,760 | Institution | 4.70% | 93,796,965 | |
| 893,651 | Institution | 1.05% | 20,982,925 | |
| 833,961 | Institution | 0.98% | 19,581,404 | |
| 804,356 | Institution | 0.95% | 18,886,279 | |
| 703,088 | Institution | 0.83% | 16,508,506 | |
| 656,761 | Institution | 0.77% | 15,420,748 | |
| 607,500 | Institution | 0.71% | 14,264,100 | |
| 573,848 | Institution | 0.68% | 13,473,951 | |
| 494,654 | Institution | 0.58% | 11,614,476 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,590,730 | Institution | 3.05% | 49,923,367 | |
| 2,007,783 | Institution | 2.36% | 47,182,901 | |
| 1,808,638 | Institution | 2.13% | 42,502,993 | |
| 1,266,916 | Institution | 1.49% | 24,413,471 | |
| 728,328 | Institution | 0.86% | 17,101,141 | |
| 584,465 | Institution | 0.69% | 13,723,238 | |
| 381,487 | Institution | 0.45% | 8,964,945 | |
| 295,534 | Institution | 0.35% | 5,694,940 | |
| 260,167 | Institution | 0.31% | 5,013,418 | |
| 100,518 | Institution | 0.12% | 2,362,173 |
FAQ
Who Owns Syndax Pharmaceuticals Inc (SNDX)?
According to the latest TipRanks data, approximately 13.23% of the company's stock is held by institutional investors, 1.06% is held by insiders, and 64.01% is held by retail investors.
What percentage of Syndax Pharmaceuticals Inc (SNDX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.23% of Syndax Pharmaceuticals Inc (SNDX) stock is held by institutional investors.
What percentage of Syndax Pharmaceuticals Inc (SNDX) stock is held by retail investors?
According to the latest TipRanks data, approximately 64.01% of Syndax Pharmaceuticals Inc (SNDX) stock is held by retail investors.
Who owns the most shares of Syndax Pharmaceuticals Inc (SNDX)?
Vanguard owns the most shares of Syndax Pharmaceuticals Inc (SNDX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.